These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

785 related items for PubMed ID: 21115061

  • 1. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
    Abelin A, Colegate T, Gardner S, Hehme N, Palache A.
    Vaccine; 2011 Feb 01; 29(6):1135-8. PubMed ID: 21115061
    [Abstract] [Full Text] [Related]

  • 2. [Influenza vaccine: globalization of public health stakes].
    Collin N, Briand S.
    Med Trop (Mars); 2009 Aug 01; 69(4):322. PubMed ID: 19725377
    [Abstract] [Full Text] [Related]

  • 3. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.
    Collin N, de Radiguès X, World Health Organization H1N1 Vaccine Task Force.
    Vaccine; 2009 Aug 20; 27(38):5184-6. PubMed ID: 19563891
    [Abstract] [Full Text] [Related]

  • 4. Experience and lessons from surveillance and studies of the 2009 pandemic in Europe.
    Nicoll A, Ammon A, Amato Gauci A, Ciancio B, Zucs P, Devaux I, Plata F, Mazick A, Mølbak K, Asikainen T, Kramarz P.
    Public Health; 2010 Jan 20; 124(1):14-23. PubMed ID: 20141821
    [Abstract] [Full Text] [Related]

  • 5. Pandemic influenza A (H1N1) 2009 vaccine: an update.
    Goel MK, Goel M, Khanna P, Mittal K.
    Indian J Med Microbiol; 2011 Jan 20; 29(1):13-8. PubMed ID: 21304188
    [Abstract] [Full Text] [Related]

  • 6. Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza.
    Prosper O, Saucedo O, Thompson D, Torres-Garcia G, Wang X, Castillo-Chavez C.
    Math Biosci Eng; 2011 Jan 20; 8(1):141-70. PubMed ID: 21361405
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A pandemic influenza vaccine in India: from strain to sale within 12 months.
    Dhere R, Yeolekar L, Kulkarni P, Menon R, Vaidya V, Ganguly M, Tyagi P, Barde P, Jadhav S.
    Vaccine; 2011 Jul 01; 29 Suppl 1():A16-21. PubMed ID: 21684421
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries.
    Rudenko L, van den Bosch H, Kiseleva I, Mironov A, Naikhin A, Larionova N, Bushmenkov D.
    Vaccine; 2011 Jul 01; 29 Suppl 1():A40-4. PubMed ID: 21684428
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An international technology platform for influenza vaccines.
    Hendriks J, Holleman M, de Boer O, de Jong P, Luytjes W.
    Vaccine; 2011 Jul 01; 29 Suppl 1():A8-11. PubMed ID: 21684431
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.